Hospital for Special Surgery
New York, 10021, United States
NCT Number: NCT01505465
Pain, confusion, and breaks in normal sleep cycles have been challenges commonly faced by patients after undergoing joint surgeries. To address these issues, melatonin, an inexpensive over-the-counter supplement, has shown in previous to help manage sleep disorders, prevent and treat post-operative confusion in patients over 70 years of age, and reduce pain. The purpose of this study is to establish whether melatonin can aid in reducing pain and post-operative confusion and improve sleep quality after total knee replacement
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
New York, 10021, United States
Sleep disruption is a challenge commonly faced by patients and care providers in the perioperative period [1,2] and has been shown to affect postoperative performance after total knee arthroplasty [3] . Postoperative sleep disruption is likely influenced by environmental factors [4] and anesthetic exposure [5,6] and is known to be exacerbated by postoperative pain [7] . In a reciprocal manner, sleep disruption has been shown to exacerbate pain perception [8,9] .
Melatonin is an inexpensive over-the-counter dietary supplement with an established safety profile [10] that has shown promise in managing sleep disorders and amelioration of chronic and acute pain. Evidence suggests that exogenous melatonin can be efficacious in improving sleep disruption in tracheostomized patients in the ICU [11] as well as those experiencing jet lag [12,13] .
Previous studies have found conflicting results regarding the potential for melatonin to improve sleep and pain in the perioperative period [14] . These discrepancies may result from differences in surgical and anesthetic conditions, differences in melatonin dose and administration regimens, variations in study quality, different methods of assessing pain and sleep quality, and different patient populations. There is no consensus as to what dose, duration, and timing of melatonin administration in the perioperative period are most likely to improve sleep quality or quantity. This study was designed to explore the effect of a stable regimen of exogenous perioperative melatonin, administered over 6 consecutive nights, on postoperative pain, sleep quality, and sleep efficiency in patients undergoing total knee arthroplasty under regional anesthesia with sedation. To our knowledge, this study is the first to examine perioperative subjected sleep quality as well as sleep time and efficiency as measured by the validated objective tool of wrist actigraphy in this population.
This study examined the hypotheses that sleep disruption occurs in the context of total knee arthroplasty performed under regional anesthesia with sedation and that perioperative melatonin can modulate pain and sleep disruption after total knee arthroplasty.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
5mg of melatonin will be taken by the subject for 3 nights prior and continuing 3 nights after surgery as tolerated.
5mg of placebo will be taken by the subject 3 nights prior to surgery and continuing 3 nights after surgery
Time frame: 96 hours before surgery to 72 hours after surgery
Sleep time change from 96 hours before surgery to 72 hours after surgery
Time frame: Up to postoperative day 3
A difference in 25% in average pain score at each time point be considered clinically significant.
Time frame: Up to postoperative day 3
A difference of 25% will be considered clinically important.
Time frame: Up to postoperative day 3
A 20% difference will be considered clinically important.
Time frame: Up to 3 days
A 25% in narcotic usage will be considered clinically important
Hospital for Special Surgery, New York
Other
Effects of Perioperative Melatonin on Sleep, Pain, and Confusion After Joint Replacement Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00221338
Cognition Disorders, Cognitive Dysfunction
San Francisco, California, United States
View Trial DetailsNCT02417337
Irreversible Pulpitis, Neurologic Manifestations
Khartoum, Sudan
View Trial DetailsNCT07568327
Free Gingival Graft, Neurologic Manifestations
Istanbul, Turkey, Turkey (Türkiye)
View Trial DetailsNCT05854537
Hemorrhage, Neurologic Manifestations
Cairo, Cairo Governorate, Egypt
View Trial Details